HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Intimate Brands/Shiseido appointment

This article was originally published in The Rose Sheet

Executive Summary

Kevin Mead to VP-chief stores officer, leading store organization for the Intimate Brands/Shiseido joint venture, IBI announces. Mead currently is VP-store operations for Victoria's Secret Beauty. In his new post, Mead will report to Exec VP and General Manager Lynn Emmolo and will be responsible for store operations, store communications and visual merchandising. Intimate Brands and Shiseido announced they would enter into a joint venture to market prestige beauty product in September 2000 (11"The Rose Sheet" September 18, 2000, p. 3). Bath & Body Works exec Kimberly Draper to senior VP-chief stores operator for Victoria's Secret Beauty...

You may also be interested in...



Intimate Brands/Shiseido Joint Retail Stores Open Fall 2001

A joint venture between Shiseido and Intimate Brands, Inc. (IBI) will give birth to approximately 500 open-sell, free-standing stores marketing a yet-to-be-developed prestige beauty brand, the companies announced Sept. 14.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009962

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel